Indoco Remedies

Indoco Remedies Inventory

The Inventory of Indoco Remedies (INDOCO.NS) as of Oct 16, 2026 is 4.05 B INR. In the previous year, Inventory was 4.19 B INR — a change of -3.37% (lower).

Inventory

4.05 BINR

YoY

-3.37%

Last updated:

Inventory of Indoco Remedies is 2026 4.05 B INR. Inventory of Indoco Remedies was 2025 4.19 B INR. It decreases by -3.37% lower compared to the previous year.

The Indoco Remedies Inventory history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Inventory
Date
Inventory
Jan 1, 2019
1.83 B INR
Jan 1, 2020
2.08 B INR
Jan 1, 2021
2.38 B INR
Jan 1, 2022
3.11 B INR
Jan 1, 2023
3.26 B INR
Jan 1, 2024
3.53 B INR
Jan 1, 2025
4.19 B INR
Jan 1, 2026
4.05 B INR
The Indoco Remedies Inventory history
YEARInventoryYoY
4.05 BINR-3.37%
4.19 BINR+18.77%
3.53 BINR+8.31%
3.26 BINR+4.98%
3.11 BINR+30.55%
2.38 BINR+14.18%
2.08 BINR+13.55%
1.83 BINR-5.14%
1.93 BINR+3.44%
1.87 BINR+13.17%
1.65 BINR+10.78%
1.49 BINR+35.30%
1.10 BINR—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Indoco Remedies Stock analysis

What does Indoco Remedies do? Indoco Remedies Ltd, listed on the National Stock Exchange of India with ticker INDOCO.NS and ISIN INE873D01024, is a pharmaceutical company headquartered in Mumbai, India. The company operates within the Health Care sector, specifically in the Pharmaceuticals industry. It employs 6,101 full-time employees and went public via an IPO on January 7, 2005. Indoco Remedies Ltd focuses on the manufacturing and marketing of formulations, including finished dosage forms and active pharmaceutical ingredients (APIs). The company serves multiple therapeutic categories such as diabetology, respiratory care, stomatology, women's health, nutritional products, gastroenterology, cardiology, metabolic disorders, and primary care medicine. Its product portfolio includes brands like Cyclopam, Sensodent-K, Karvol Plus, Sensoform, Cital UTI, Kidodent, Rexidin M, Lignox A, Dentogel, Aloja, Homide, Renolen, Noxa, Dexoren - S, Aloja M, ATM, Febrex Plus, Sensodent-KF, SM Fibro, MCBM 69, Cal Aid, Snowdent, Dropizin, Zincoren, Coloferrin, Bfloren, RR Sensoform Dental, Mofloren-D, and Tuspel. The company caters to both domestic and international markets. Indoco Remedies Ltd has subsidiaries including Xtend Industrial Designers and Engineers Pvt Ltd, Indoco Remedies Czech sro, and Indoco Remedies UK Limited. The company's website is https://www.indoco.com/. Indoco Remedies is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Indoco Remedies stock

Inventory of Indoco Remedies is 4.05 B INR in 2026.

Inventory of Indoco Remedies changed from 4.19 B INR to 4.05 B INR, representing a -3.37% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Inventory Indoco Remedies since 2006 – with annual values, charts, and detailed analysis.

Inventory includes raw materials, work-in-progress, and finished goods. Efficient inventory management is crucial for profitability.

Inventory's INR is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Inventory's Indoco Remedies historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Balance Sheet — Indoco Remedies

Total AssetsCurrent AssetsCash & EquivalentsReceivablesInventoryProperty, Plant & EquipmentGoodwillIntangible AssetsEquityLiabilitiesDebtCurrent LiabilitiesLong-term DebtShort-term DebtRetained EarningsBook Value per ShareTangible Book Value per ShareWorking CapitalInvestmentsAccounts PayableNon-Current AssetsShort-Term InvestmentsLong-Term InvestmentsNet DebtTreasury StockMinority InterestDeferred Tax LiabilitiesNet Tangible AssetsGoodwill/AssetsIntangibles/Assets

All Key Metrics — Indoco Remedies